Cannara Biotech (LOVE) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period LOVFF Cannara Biotech Inc.February 20 at 8:42 PM | seekingalpha.comCannara Biotech (CVE:LOVE) shareholders notch a 42% return over 1 year, yet earnings have been shrinkingFebruary 6, 2025 | finance.yahoo.comCannara Biotech Reports Record Q1 2025 ResultsFebruary 3, 2025 | tipranks.comCannara Biotech GAAP EPS of C$0.03, revenue of C$25.1MJanuary 27, 2025 | seekingalpha.comCannara Biotech Achieves Record Growth in Q1 2025, Plans ExpansionJanuary 27, 2025 | tipranks.comWe Like These Underlying Return On Capital Trends At Cannara Biotech (CVE:LOVE)January 10, 2025 | finance.yahoo.comCannara Biotech Hosts Investor Webcast in DecemberDecember 13, 2024 | markets.businessinsider.comCannara Biotech to Host Investor Webcast on Thursday December 19th, 2024December 12, 2024 | financialpost.comCannara Biotech Full Year 2024 Earnings: EPS: CA$0.071 (vs CA$0.078 in FY 2023)November 26, 2024 | finance.yahoo.comCanadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And ProfitabilityNovember 25, 2024 | benzinga.comCannara reports record growth and profitability in Q4 2023November 25, 2024 | msn.comCannara Biotech Reports Record Growth in 2024November 25, 2024 | tipranks.comCannara Biotech reports Q4 EPS C$0.06 vs. C$0.05 last yearNovember 25, 2024 | tipranks.comThere's Been No Shortage Of Growth Recently For Cannara Biotech's (CVE:LOVE) Returns On CapitalJuly 27, 2024 | finance.yahoo.comCannara Biotech Inc (LOVE)July 24, 2024 | investing.comCannara Biotech Inc.: Cannara Biotech Reports Q3 2024 Financial ResultsJuly 23, 2024 | finanznachrichten.deCannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And InfrastructureJuly 23, 2024 | benzinga.comCannara Biotech Reports Q3 2024 Financial ResultsJuly 23, 2024 | finance.yahoo.comCannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net LossMay 1, 2024 | benzinga.comPharmaCann Partners With CAMApril 26, 2024 | msn.comInsider Spends US$434k Buying More Shares In LovesacApril 22, 2024 | finance.yahoo.comThe Lovesac Company (NASDAQ:LOVE) Q4 2024 Earnings Call TranscriptApril 16, 2024 | finance.yahoo.comQ4 2024 Lovesac Co Earnings CallApril 12, 2024 | finance.yahoo.comThe Lovesac Co (LOVE) Q4 2024 Earnings Call Transcript Highlights: Navigating Industry ...April 12, 2024 | finance.yahoo.comThe Lovesac Company (NASDAQ:LOVE) Shares Could Be 38% Below Their Intrinsic Value EstimateApril 12, 2024 | finance.yahoo.comLovesac (LOVE) Q4 2024 Earnings Call TranscriptApril 11, 2024 | fool.comCannara Biotech Inc.April 9, 2024 | wsj.comCannara Biotech Inc.'s (CVE:LOVE) Stock Been Rising: Are Strong Financials Guiding The Market?March 20, 2024 | finance.yahoo.comReturns On Capital Are Showing Encouraging Signs At Lovesac (NASDAQ:LOVE)March 11, 2024 | finance.yahoo.comCannara Biotech Stock (OTC:LOVFF), Insider Trading ActivityFebruary 25, 2024 | benzinga.comWith EPS Growth And More, Cannara Biotech (CVE:LOVE) Makes An Interesting CaseFebruary 21, 2024 | finance.yahoo.comShareholders in Lovesac (NASDAQ:LOVE) are in the red if they invested three years agoFebruary 13, 2024 | finance.yahoo.com4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market DipFebruary 10, 2024 | fool.comCannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company's First Export SaleFebruary 7, 2024 | benzinga.comCannara Biotech Inc.: Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market ExpansionJanuary 30, 2024 | finanznachrichten.deCannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market ExpansionJanuary 30, 2024 | finance.yahoo.com4 Spectacular Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear-Market DipJanuary 27, 2024 | fool.comThe past five years for Cannara Biotech (CVE:LOVE) investors has not been profitableJanuary 23, 2024 | finance.yahoo.comCannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")January 8, 2024 | finance.yahoo.comFounder and CEO of The Lovesac Company Publishes Candid Origin StoryJanuary 2, 2024 | finance.yahoo.comCannara Biotech Stock (OTC:LOVFF) Dividends: History, Yield and DatesDecember 21, 2023 | benzinga.comThe Lovesac Company Publishes 2023 ESG ReportDecember 18, 2023 | finance.yahoo.comThe Lovesac Company (NASDAQ:LOVE) Looks Just Right With A 50% Price JumpDecember 18, 2023 | finance.yahoo.comLovesac Unveils Swarovski Crystal Embellished Footsac, Perfect for Holiday GiftingDecember 15, 2023 | finance.yahoo.comInsiders of Lovesac Getting Good Value On Their US$1.26m InvestmentDecember 8, 2023 | finance.yahoo.comLovesac (LOVE) Q3 Earnings & Revenues Beat Estimates, Up Y/YDecember 7, 2023 | finance.yahoo.comCannara Biotech Inc.: Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability ContinuesDecember 7, 2023 | finanznachrichten.deCannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability ContinuesDecember 7, 2023 | finance.yahoo.comLovesac being cautious as consumer face headwinds: CEODecember 7, 2023 | finance.yahoo.comLovesac (LOVE) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesDecember 6, 2023 | finance.yahoo.com Get Cannara Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LOVE and its competitors with MarketBeat's FREE daily newsletter. Email Address LOVE Media Mentions By Week LOVE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LOVE News Sentiment▼0.000.61▲Average Medical News Sentiment LOVE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LOVE Articles This Week▼10▲LOVE Articles Average Week Get Cannara Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LOVE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Quanta Services News Today Bausch Health Companies News Today Tilray Brands News Today Cronos Group News Today Knight Therapeutics News Today Aurora Cannabis News Today Canopy Growth News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CNSX:LOVE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cannara Biotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Cannara Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LOVE Stock Alerts